Compositions and methods for genetic analysis of polycystic kidney disease
CA 2872385 C · Owner: Athena Diagnostics, Inc. · Inventors: Palatucci, Christopher M.; Flynn, Kerry E.; Allen, Susan K.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention relates to nucleic acid sequences for detection of mutations in a PKD-1 or PKD-2 gene as well as biomarkers for ADPKD. The invention further relates to methods for diagnosing ADPKD in an individual and kits for performing the methods of the invention. The invention also provides a method for determining in an individual the presence or absence of a mutant PKD gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 8, 2004 and granted January 15, 2019. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 8, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 8, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.